Phase III trials with docetaxel-based combinations for metastatic castration-resistant prostate cancer: Time to learn from past experiences

Emmanuel S. Antonarakis; Mario A. Eisenberger

doi:10.1200/JCO.2013.48.8825

Phase III trials with docetaxel-based combinations for metastatic castration-resistant prostate cancer: Time to learn from past experiences

Emmanuel S. Antonarakis
, Mario A. Eisenberger

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1709-1712
Number of pages	4
Journal	Journal of Clinical Oncology
Volume	31
Issue number	14
DOIs	https://doi.org/10.1200/JCO.2013.48.8825
State	Published - May 10 2013
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Publisher link

10.1200/JCO.2013.48.8825

Find It

Find It at U of M Libraries

Cite this

@article{1efb6b5369a24865a2da2da12c05245e,

title = "Phase III trials with docetaxel-based combinations for metastatic castration-resistant prostate cancer: Time to learn from past experiences",

author = "Antonarakis, \{Emmanuel S.\} and Eisenberger, \{Mario A.\}",

year = "2013",

month = may,

day = "10",

doi = "10.1200/JCO.2013.48.8825",

language = "English (US)",

volume = "31",

pages = "1709--1712",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "14",

}

TY - JOUR

T1 - Phase III trials with docetaxel-based combinations for metastatic castration-resistant prostate cancer

T2 - Time to learn from past experiences

AU - Antonarakis, Emmanuel S.

AU - Eisenberger, Mario A.

PY - 2013/5/10

Y1 - 2013/5/10

UR - https://www.scopus.com/pages/publications/84879469745

UR - https://www.scopus.com/pages/publications/84879469745#tab=citedBy

U2 - 10.1200/JCO.2013.48.8825

DO - 10.1200/JCO.2013.48.8825

M3 - Editorial

C2 - 23569320

AN - SCOPUS:84879469745

SN - 0732-183X

VL - 31

SP - 1709

EP - 1712

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 14

ER -

Phase III trials with docetaxel-based combinations for metastatic castration-resistant prostate cancer: Time to learn from past experiences

UN SDGs

Publisher link

Find It

Other files and links

Cite this